•
Dec 31, 2022

Arrowhead Pharmaceuticals Q1 2023 Earnings Report

Total Revenue
$62.5M
Previous year: $27.4M
+127.9%
EPS
-$0.39
Previous year: -$0.6
-35.0%
Gross Profit
$59.9M
Previous year: $24.9M
+140.7%
Cash and Equivalents
$202M
Previous year: $91.6M
+120.8%
Free Cash Flow
-$114M
Previous year: -$67.1M
+70.6%
Total Assets
$891M
Previous year: $639M
+39.6%

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals